In summary, it is possible that ALDH1A1 expression and activity in DCIS.com and SUM225 CCR2-overexpressing breast cancer cells may facilitate cell growth through metabolites that activate oncogenic pathways. The gene discussed is ALDH1A1; the disease is ductal breast carcinoma in situ.